A high-quality insurance brokerage franchise with excellent cash conversion and an unbroken four-quarter earnings beat streak is navigating a confirmed near-term price downtrend with heavy revenue concentration in a single business segment—warranting a patient, watch-and-wait stance while the technical setup stabilizes.
Thesis pillars
- Revenue Concentrated In Single Segment↑Improving
- Quality Franchise Exceptional Cash Conversion→Stable
- Confirmed Near Term Price Downtrend↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 9, 2026· older than 90 days
Marsh (MRSH) Stock Analysis
Financial Services · Insurance Brokers
Hold if already holding. Not a fresh buy at $210.38, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%).
Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) —... Read more
Hold if already holding. Not a fresh buy at $210.38, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 5.6/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 84d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
No fresh coverage since Oct 15, 2026
Recent Developments — Marsh
Latest news
- NEWS Why Marsh (MRSH) Stock Is Trading Up Today - Yahoo Finance — Yahoo Finance Oct 15, 2026 positive
- NEWS Marsh McLennan (MRSH) vs Aon (AON): Which Insurance Broker is a Better Buy? - Yahoo Finance — Yahoo Finance Oct 14, 2026 neutral
- NEWS Earnings To Watch: Marsh (MRSH) Reports Q3 Results Tomorrow - TradingView — TradingView Oct 14, 2026 neutral
- NEWS KBW Sticks to Their Hold Rating for Marsh & McLennan Companies (MRSH) - The Globe and Mail — The Globe and Mail Oct 13, 2026 neutral
- NEWS Marsh & McLennan Companies (MRSH) Could Be 59% Undervalued After East Region Reshuffle - Simply Wall Street — Simply Wall Street Oct 13, 2026 positive
Latest item Oct 15, 2026 · Generated 2026-11-05T11:49:11Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductRisk and Insurance Services64%10-K Item 1: 'RISK AND INSURANCE SERVICES ... accounted for approximately 64% of the Company's total revenue in 2025'
- HIGHProductMarsh Risk54%10-K Item 1: 'MARSH RISK ... generated approximately 54% of the Company's total revenue in 2025'
Material Events(8-K, last 90d)
- 2026-06-04Item 1.01MEDIUMMarsh entered a new Amended and Restated 5-year $4.25 billion multi-currency unsecured revolving credit facility with Citibank, N.A. as administrative agent, maturing June 2031. Interest at Term SOFR plus a fixed margin varying with Marsh's credit ratings.SEC filing →
- 2026-06-04Item 1.02MEDIUMPrior revolving credit facility terminated in connection with entry into Amended and Restated 5-year $4.25 billion credit agreement with Citibank, N.A. dated June 2, 2026. No reason cited beyond routine refinancing and extension.SEC filing →
- 2026-04-14Item 5.02LOWMark McGivney appointed EVP, Chief Operating Officer & CFO effective April 15, 2026, expanding his role from SVP and CFO (held since January 2016). Annual base salary set at $1,250,000. McGivney retains CFO title; no separate CFO successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $210.38, but acceptable to hold if already in. Reasons: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $185.96 reached (−11.6%), stop $200.68 (−4.8%), A.R:R -0.8:1. Score 5.6/10, moderate confidence.
Analyst target $185.96 reached (−11.6% from $210.38); no take-profit level is published. Analyst target $185.96 reached (−11.6%), stop $200.68 (−4.8%), A.R:R -0.8:1. Stop-loss: $200.68.
Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%); Analyst target reached - limited upside remaining.
Marsh trades at a P/E of 25.2 (forward 18.4). TrendMatrix value score: 5.0/10. Verdict: Hold.
31 analysts rate MRSH, with a consensus score of 3.5/5. 21 analysts publish price targets averaging $207.
What does Marsh do?Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance...
Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) — advising clients in 130 countries with over 95,000 employees. Revenue comes from insurance and reinsurance broking commissions, client fees for consulting and investment management, and fiduciary interest income on premiums held for clients.